Todd Zavodnick
Chief Executive Officer at Dermavant Sciences Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Foley | M | 58 | 12 years | |
| Kenneth Ludlum | M | 70 |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018.
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | 5 years |
| Timothy Nelson | M | 60 |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018.
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | 5 years |
| Ambrose Bailey | M | 60 | 7 years | |
| Tobin Schilke | M | 49 | 6 years | |
| Myrtle Potter | F | 65 |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom.
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 6 years |
| Yen You Zheng | M | 67 | 5 years | |
| Frank Torti | M | 45 |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom.
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 6 years |
| Sigurd Kirk | M | 57 | 7 years | |
| Nancy Beesley | F | - |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 2 years |
| Conor Gallagher | M | - | 6 years | |
| Kira Schwartz | F | - | 7 years | |
| James Joseph Florio | M | 86 |
Rutgers State University of New Jersey
| 30 years |
| Michael Clement | M | 67 |
The University of Texas at Austin
| 20 years |
| Frederick C. Beddingfield | M | 59 |
Children's Skin Disease Foundation
| - |
| Merrick McCracken | M | - |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | 14 years |
| Igor Correia de Almeida | M | 63 |
The University of Texas at Austin
| 20 years |
| John Donofrio | M | 56 |
Children's Skin Disease Foundation
| - |
| Chris Chapman | M | - |
Dermavant Sciences Ltd.
Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | 4 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark M. Sieczkarek | M | 69 | 5 years | |
| John J. McGovern | M | - | 2 years | |
| Dustin Sjuts | M | 45 | 6 years | |
| Richard A. Leavy | M | - |
Rutgers State University of New Jersey
| 9 years |
| Cyril Allouche | M | 52 | 2 years | |
| Mohammed Hoque | M | 46 |
The University of Texas at Austin
| 5 years |
| Eric Pearson | M | - |
The University of Texas at Austin
| 5 years |
| Prem Nainani | M | - |
The University of Texas at Austin
| 6 years |
| Joel A. Shapiro | M | 53 |
Rutgers State University of New Jersey
| 7 years |
| Stuart Raetzman | M | 61 |
Galderma Laboratories LP
 Galderma Laboratories LP Pharmaceuticals: MajorHealth Technology Galderma Laboratories LP develops and markets dermatology and prescription products. It also offers treatments for skin conditions such as acne, rosacea, atopic dermatitis, soriasis, melasma and sunspots. Galderma Laboratories was founded in 1961 and is headquartered in Fort Worth, TX.
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | - |
| Jim Ciprich | M | - |
Rutgers State University of New Jersey
| 6 years |
| Hemant Pande | M | - |
Rutgers State University of New Jersey
| 5 years |
| Phillip C. Zerrillo | M | 65 |
The University of Texas at Austin
| 5 years |
| Kendall Helfenbein | M | - |
The University of Texas at Austin
| 4 years |
| Matthew D. Boyd | M | - |
The University of Texas at Austin
| 5 years |
| Brendan Achariyakosol | M | - |
The University of Texas at Austin
| 11 years |
| Danika R. Harrison | F | 48 | 3 years | |
| Joel Marc Kallman | M | - |
Rutgers State University of New Jersey
| - |
| Natasha Tosirisuk | F | - |
The University of Texas at Austin
| 5 years |
| Andrew Schiff | M | 58 | 7 years | |
| Chien Chung Nieh | M | 64 |
Rutgers State University of New Jersey
| 4 years |
| Justin Bernard Smith | M | - |
The University of Texas at Austin
| 5 years |
| Alex Greyserman | M | - |
Rutgers State University of New Jersey
| 5 years |
| Caryn McDowell | F | 54 | - | |
| Marvin Kwan | M | - |
The University of Texas at Austin
| 5 years |
| Turab Bajwa | M | - |
The University of Texas at Austin
| 5 years |
| Sam F. Stoutner | M | 37 |
The University of Texas at Austin
| 5 years |
| Steven Hirsch | M | - |
The University of Texas at Austin
| 5 years |
| Rui Mao | M | 49 |
The University of Texas at Austin
| 3 years |
| Christy Cardenas | F | 37 |
The University of Texas at Austin
| 5 years |
| Kyle Hranicky | M | - |
The University of Texas at Austin
| 5 years |
| John Batton | M | - |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | 3 years |
| Megan Light | F | - |
The University of Texas at Austin
| 5 years |
| SHORT REBECCA | F | - |
The University of Texas at Austin
| 4 years |
| Daniel G. Polhamus | M | - |
The University of Texas at Austin
| 5 years |
| Rachel Foley | F | - |
The University of Texas at Austin
| 4 years |
| John Blair Cummings | M | - |
Rutgers State University of New Jersey
| 11 years |
| Ali Merchant | M | - |
The University of Texas at Austin
| 5 years |
| Mary Fisher | F | 62 | 5 years | |
| Kevin O'Boyle | M | 68 | 6 years | |
| T. Alex McPherson | M | 85 | 10 years | |
| Sergio Garcia-Rodriguez | M | 62 | 5 years | |
| Michael Schemick | M | 50 |
Rutgers State University of New Jersey
| 6 years |
| Leonard Goldberg | M | 61 |
Rutgers State University of New Jersey
| 13 years |
| D. Grossman | M | 63 | 4 years | |
| Zhaobo Wang | M | 67 |
Rutgers State University of New Jersey
| 4 years |
| David Endicott | M | 58 | 1 years | |
| Keith Sullivan | M | 65 | 5 years | |
| Michael Ian Mellon | M | - |
The University of Texas at Austin
| 5 years |
| Ronald Eastman | M | 71 | 8 years | |
| B. M. Rankin | M | 94 |
The University of Texas at Austin
| 7 years |
| Ashley Baum | F | - |
The University of Texas at Austin
| 5 years |
| Bryan Roberts | M | 57 | 8 years | |
| Patrick Williams | M | 51 | 4 years | |
| Lauren Silvernail | F | 65 | 5 years | |
| Massimo Radaelli | M | 65 | 2 years | |
| Vincent Ippolito | M | 65 |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | 2 years |
| Shari Ledbetter | F | - |
The University of Texas at Austin
| 5 years |
| Wesley Gallup | M | - |
The University of Texas at Austin
| 6 years |
| John Moran | M | 48 |
Rutgers State University of New Jersey
| 6 years |
| Reid Callaway | M | - |
The University of Texas at Austin
| 4 years |
| Nikhil N. Sinha | M | 63 |
The University of Texas at Austin
| 3 years |
| Kevin J. L’abbé | M | 43 |
The University of Texas at Austin
| 4 years |
| Matthew Hartman | M | - |
The University of Texas at Austin
| 2 years |
| Naveen Jayasundaram | M | - |
The University of Texas at Austin
| 4 years |
| Chris Halaska | M | - |
The University of Texas at Austin
| 2 years |
| Tuan Phu Pham | M | - |
The University of Texas at Austin
| 2 years |
| Rahul Anne | M | - |
The University of Texas at Austin
| 4 years |
| Anthony Young | M | - |
The University of Texas at Austin
| 2 years |
| Stephen J. Spann | M | - |
The University of Texas at Austin
| 2 years |
| Ryan Pollock | M | - |
The University of Texas at Austin
| 2 years |
| Patrick Lissonnet | M | - |
The University of Texas at Austin
| 2 years |
| Jack Foster | M | - |
The University of Texas at Austin
| 4 years |
| Kristal Pei Ying Tran Choy | F | - |
The University of Texas at Austin
| 3 years |
| Blair Morrison | F | - |
The University of Texas at Austin
| 4 years |
| Jennifer Wenzel | F | - |
The University of Texas at Austin
| 4 years |
| Todd A. Parsapour | M | - |
The University of Texas at Austin
| 2 years |
| Darin Turner | M | 45 |
The University of Texas at Austin
| 1 years |
| Bagot Drew | M | - |
The University of Texas at Austin
| 4 years |
| Lance Mu | M | - |
The University of Texas at Austin
| 2 years |
| Said Aziz | M | - |
The University of Texas at Austin
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 86 | 86.00% |
| France | 13 | 13.00% |
| United Kingdom | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Todd Zavodnick
- Personal Network
